This first legislative review will focus on the vaping-related objectives of the Act
March 16, 2022 | Ottawa, ON | Health Canada
The Government of Canada strives to protect the health of Canadians from nicotine addiction and tobacco use. To support this, the Tobacco and Vaping Products Act (TVPA) was amended in 2018, with a focus on preventing uptake by youth and those who do not use tobacco products. The Government of Canada is inviting the public to provide feedback on how the Act is progressing towards achieving its vaping-related objectives.
The TVPA regulates the manufacture, sale, labelling and promotion of both tobacco and vaping products sold in Canada. The Act underscores that these products are harmful to young people as well as to people who don’t use tobacco products. It also recognizes that vaping products are a less harmful source of nicotine for adults who smoke and choose to switch completely.
The TVPA includes a requirement for a legislative review three years after coming into force, followed by subsequent reviews every two years. This requirement is an opportunity to monitor the TVPA’s new oversight of vaping products with particular focus on its impact on youth vaping. Regular reviews will help Canada remain vigilant in addressing the important public health issues related to tobacco and vaping products.
Specifically, this first review will focus on the TVPA’s progress towards meeting the following objectives:
- Protecting young people and non-users of tobacco products from inducements to use vaping products;
- Protecting the health of young persons and non-users of tobacco products from exposure to and dependence on nicotine that could result from the use of vaping products;
- Protecting the health of young persons by restricting access to vaping products;
- Preventing the public from being deceived or misled with respect to the health hazards of using vaping products; and
- Enhancing public awareness of those hazards.
Canadians are encouraged to consult Health Canada’s TVPA Discussion Paper and submit their feedback by emailing legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca until April 27, 2022.
The public consultation will inform the development of a final report that is required to be tabled in Parliament. The final report will be publicly available on Canada.ca.
Health Canada – 2022-03-15.
Want More Investigative Content?
